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Molecular profiling of tissue biopsies reveals
unique signatures associated with streptococcal
necrotizing soft tissue infections
Robert Thänert 1,11, Andreas Itzek1,11, Jörn Hoßmann1, Domenica Hamisch1, Martin Bruun Madsen2,
Ole Hyldegaard3, Steinar Skrede4,5, Trond Bruun 4, Anna Norrby-Teglund6, INFECT study group,
Eva Medina7,11 & Dietmar H. Pieper1,11
Necrotizing soft tissue infections (NSTIs) are devastating infections caused by either a single
pathogen, predominantly Streptococcus pyogenes, or by multiple bacterial species. A better
understanding of the pathogenic mechanisms underlying these different NSTI types could
facilitate faster diagnostic and more effective therapeutic strategies. Here, we integrate
microbial community profiling with host and pathogen(s) transcriptional analysis in patient
biopsies to dissect the pathophysiology of streptococcal and polymicrobial NSTIs. We
observe that the pathogenicity of polymicrobial communities is mediated by synergistic
interactions between community members, fueling a cycle of bacterial colonization and
inflammatory tissue destruction. In S. pyogenes NSTIs, expression of specialized virulence
factors underlies infection pathophysiology. Furthermore, we identify a strong interferon-
related response specific to S. pyogenes NSTIs that could be exploited as a potential diag-
nostic biomarker. Our study provides insights into the pathophysiology of mono- and poly-
microbial NSTIs and highlights the potential of host-derived signatures for microbial diagnosis
of NSTIs.
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Necrotizing soft tissue infections (NSTIs) are life-threateningbacterial infections characterized by rapidly spreadingnecrosis of the skin and subcutaneous tissues1. An immu-
nonocompromised status, caused for example by chemotherapy, can
predispose patients for NSTIs and diabetic ulcers, penetrating
trauma, breach of the epithelial barrier, cirrhosis, or minor non-
penetrating traumas are risk factors for NSTIs1. Diagnosis and
management of NSTIs can be challenging as initial signs and
symptoms can be ambiguous2. Despite the advances of modern
medicine, mortality associated with NSTIs remains as high as 30%
and escalates up to 70% if the correct clinical diagnosis is delayed3,4.
The microbial etiology of NSTIs can either be monomicrobial,
caused by a single bacterial species, or polymicrobial, caused by
diverse microorganisms. While S. pyogenes is the most common
pathogen associated with monomicrobial NSTIs1, other streptococcal
species (S. dysgalactiae, S. agalactiae) and Staphylococcus aureus have
also been reported to cause monomicrobial NSTIs5,6. Polymicrobial
NSTIs are commonly associated with a mixture of aerobic and
anaerobic bacteria7. Among these, Enterobacteriaceae, Bacteroides
spp., Porphyromonas spp., Prevotella spp., Peptostreptococcus spp.,
and Clostridium spp. have been most frequently isolated from
infected tissue2,8. Whereas polymicrobial NSTIs are usually observed
in older patients, or in individuals with underlying comorbidities
such as diabetes, monomicrobial NSTIs are more commonly asso-
ciated with trauma, surgery, or intravenous drug use1,9. The reported
relative incidence of mono- and polymicrobial NSTIs varies sub-
stantially according to the geography and the specific characteristics
of the patient cohort1.
The pathophysiology of monomicrobial NSTIs caused by S.
pyogenes has been studied extensively and many of the virulence
factors and toxins expressed by the bacterium to efficiently colo-
nize the host tissue, escape the host immune defenses and rapidly
spread to surrounding tissue have been very well characterized10.
Neutralization of toxins by intravenous administration of human
immunoglobulins has been proposed, in addition to surgical
debriment and antimicrobial treatment, as an additional adjunct
therapy to improve the outcome of NSTIs caused by S. pyogenes11.
In contrast to S. pyogenes NSTIs, mechanistic studies addressing
the pathogenic strategies and complex dynamics of bacterial
communities in polymicrobial NSTIs are lacking. This may be due
to the technical challenges associated with investigations of the
composition, structure, and activity of polymicrobial commu-
nities. Similarly, knowledge on the host response to polymicrobial
NSTIs is scarce and it is unknown if and how the host response in
polymicrobial NSTIs differs from that during monomicrobial
infections. A better understanding of these processes is, however,
crucial as it could facilitate accurate identification of the infecting
microorganism(s) and would enable to develop treatment strate-
gies tailored toward the microbial etiology.
Currently, drastic surgical debridement of the affected tissue is
essential for successful treatment of NSTIs and total or partial
limb amputation may be required in cases of severe NSTIs with
survivors facing substantial risk for long-term morbidity and
reduced quality of life12. Besides rapid surgical intervention,
antibiotic therapy constitutes the most important adjunct in
NSTIs treatment13. Empiric antibiotic treatment commonly
consists of a mixture of broad-spectrum ß-lactams and flur-
oquinolones with antimicrobials used to treat anaerobic infec-
tions, such as Clindamycin or Metronidazole4. Once the
causative agent(s) has been identified, antibiotic treatment
regimes are revised to more specifically target the bacteria pre-
sent within the infected tissue. To date, clinical microbial diag-
nosis of NSTIs is mostly based on bacterial cultures of pre- and
intraoperatively obtained tissue- and blood samples4. In clinical
practice, one major challenge in treating severe NSTIs is the time
required for diagnosis. Therefore, diagnostic tools for NSTIs
need to be re-evaluated since the time effectiveness of the ther-
apeutic intervention will increase the chances of survival of
the patient. Conceptually, shortening the diagnostic time by the
implementation of next-generation molecular tools that enable
simultaneous identification of multiple microbes directly from
clinical samples as well as easy to measure surrogate biomarkers
of microbial etiology could accelerate and improve the man-
agement of this acute life-threatening infections. Importantly,
such markers should be invariantly associated with specific
microbial signatures and robust to fluctuations to allow reliable
diagnosis at any phase of the infection. The realization of
these diagnostic tools is hampered by a lack of basic knowledge
of the microbial diversity associated with NSTIs, their patholo-
gical mechanisms as well as the host response in real time during
infection.
In this study, we integrate microbial community profiling using
16S rRNA sequencing with transcriptional analysis of host and
microbe using dual RNA-sequencing (RNA-seq) in tissue biopsies
from NSTI patients to unravel the molecular mechanisms
underlying the pathophysiology of mono- and polymicrobial
NSTIs. Our results demonstrate that, despite the similar clinical
presentation of NSTIs, the pathophysiology of mono- and poly-
microbial etiology differs significantly and that these differences
can potentially be exploited for diagnostic purposes.
Results
Identification of bacteria present in NSTIs biopsies. To identify
the microorganisms involved in NSTIs, 16S rRNA gene sequencing
was performed in tissue biopsies obtained from 148 patients, col-
lected at five clinical sites (Table 1). Consistent with previous
reports8,14, NSTIs were either dominated by a single bacterial
pathogen or associated with a diverse spectrum of phylotypes. Taking
the alpha-diversity as a measure, 41 cases, which were dominated by
a single phylotype (>85% relative abundance), showed a
Gini–Simpson diversity index<0.25 (referred to as ‘monomicrobial’),
whereas in 54 cases no single phylotype accumulated more than one
third of sequences (Fig. 1a, Supplementary Data 1, 2, and 3). The
majority of monomicrobial NSTIs were associated with S. pyogenes
(29 of 41 cases), but other pathogens rarely reported in the context of
NSTIs, such as Staphylococcus aureus, Streptococcus dysgalactiae, and
Streptococcus agalactiae, were recovered from some of those biopsies
(Supplementary Figure 1). Clostridium sensu stricto strains, histori-
cally considered major causes of tissue necrosis15, were only sparsely
observed (Supplementary Data 1).
The composition of bacterial communities in polymicrobial
NSTIs was highly variable, but Prevotella spp., Porphyromonas
spp., Parvimonas spp., Fusobacterium spp., Peptostreptococcus
spp., and Bacteroides spp. were most frequently observed in high
abundances (Fig. 1a, Supplementary Data 1, Supplementary
Figures 2–7). Surprisingly, we observed extreme differences in the
species level diversity within these highly abundant bacterial
genera. Whereas the Bacteroides spp. abundance was dominated
by B. fragilis, which was previously characterized as a keystone
pathogen16 and accounted for 78.5% of the total genus
abundance, no single key species was observed among the other
genera, with seven species accounting for 80% of the Prevotella
genus abundance (Supplementary Figure 1).
To characterize microbial interactions within NSTIs, we inferred
bacterial co-occurrence patterns of bacterial genera using CoNet, an
ensemble method of network analysis17. We observed significant
negative associations between pathogens causing monomicrobial
NSTIs such as Streptococcus spp. and the taxonomically diverse
genera detected in polymicrobial NSTIs (Fig. 1b, Supplementary
Data 4). Using divisive clustering of co-occurring genera (see
Methods), highly interconnected clusters of bacterial genera
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associated with polymicrobial NSTIs were identified (Fig. 1b,
Supplementary Figure 8a), suggesting that these microorganisms
may act in concert to establish NSTIs.
Consistent with clinical reports18,19, the diversity and composition
of the bacterial communities in the infected tissue were highly
dependent on the affected anatomic location (Fig. 1c, Supplementary
Table 1). Thus, the bacterial diversity in NSTIs of the upper and
lower extremities was significantly lower than in NSTIs localized at
the head/neck or anogenital region indicating a higher frequency of
polymicrobial infections in the latter (Fig. 1c). Concomitantly, we
observed significantly higher abundances of gastrointestinal Bacter-
oides spp. in anogenital infections than at the extremities, while the
predominately oral genera Prevotella, Porphyromonas, and Fusobac-
terium exhibited significantly increased abundances in infections of
the head/neck area (Table 2). These observations highlight a potential
connection between bacterial community composition in NSTIs and
natural niches-associated commensals.
Pathogenicity of streptococcal and polymicrobial NSTIs dif-
fers. To characterize the mechanisms of bacterial pathogenicity
in mono- and polymicrobial NSTIs, we performed simultaneous
transcriptional profiling of infected human tissue and bacterial
gene expression analysis via dual RNA-seq. Using hierarchical
agglomerative clustering we classified patients in different clus-
ters according to the pathogen(s) and microbial community
composition associated with the obtained tissue biopsies (Fig. 2,
Supplementary Data 3). Mortality rates did not differ between
patients with either polymicrobial or streptococcal NSTIs
(Table 1, Supplementary Figure 8b). As the frequency of
monomicrobial NSTIs caused by bacteria other than Strepto-
coccus spp. was too low to enable statistical analysis, we ran-
domly selected a set of monomicrobial Streptococcus spp. NSTI
biopsies (n= 17) as well as a set of polymicrobial NSTIs (n= 22)
for in-depth transcriptional profiling (Supplementary Data 3 and
Fig. 2). A strong correlation between the relative contribution of
identified bacterial genera to the transcriptional activity and the
relative abundance of these genera within the NSTIs microbial
communities as identified by 16S rRNA gene sequencing was
observed (Supplementary Figure 9a, b). The bacterial transcrip-
tional profile indicated expression of a broader spectrum of
functionalities in polymicrobial than in monomicrobial NSTIs
(Fig. 3, Supplementary Data 5). Analysis of highly transcribed
functionalities indicated that specific pathways, such as purine
ribonucleoside salvage or glycine catabolism, were only expressed
by a fraction of the polymicrobial community, as evidenced by
low associated alpha-diversity of the genus-level transcriptional
contribution to these functionalities (Supplementary Figure 9c).
This observation may indicate functional specialization of the co-
occurring genera within the bacterial communities of poly-
microbial NSTIs. Comparative analysis of streptococcal versus
polymicrobial NSTIs indicated that carbohydrate metabolic
pathways including lactose (GO:0005990), trehalose
(GO:0005993), and galactose metabolism (Supplementary Fig-
ure 10) and carbohydrate transport (GO:0015771, GO:0008645,
GO:0034219) were strongly expressed in monomicrobial NSTIs,
while amino acid transport (GO:0006865, GO:0015813) and
metabolism (Supplementary Figure 10), and protein processing
Table 1 Clinical characteristics of patients cohort by infection type
Streptococcus
(n= 73)
Staphylococcus
(n= 5)
Bacteroides/ Escherichia
(n= 7)
Polymicrobial
(n= 45)
Other (n= 18)
Age 58.9 (8.5) 54.2 (14.9) 63.4 (16.3) 59 (13.1) 58.7 (10.8)
Gender
Female/male 28/45 0/5 1/6 23/22 8/10
Outcome
Mortality ICU (%) 6.9% 0% 14.3% 11.1% 16.7%
Mortality 1 month (%) 11.0% 0% 28.6% 13.3% 27.8%
Mortality 3 months (%) 13.7% 0% 28.6% 15.6% 27.8%
Mortality 1 year (%) 20.5% 0% 42.9% 26.7% 33.3%
Hospital
Rigshospitalet Copenhagen 37/73 4/5 4/7 25/45 12/18
Karolinska University Hospital 10/73 1/5 1/7 11/45 –
Sahlgrenska University Hospital 9/73 – 1/7 4/45 3/18
University of Bergen 15/73 – 1/7 4/45 2/18
Blekingesjukhuset Karlskrona 2/73 – – 1/45 1/18
Time from admission to surgery (hours)a 53 (114) 52 (51) 41 (90) 33 (56) 192 (504)
Laboratory values
Hemoglobin (g/l)b 9.48 (2.08) 9.89 (1.85) 7.64 (2.00) 8.82 (1.50) 8.20 (1.90)
White blood cells (109/l)c 17.18 (7.92) 20.34 (4.75) 20.94 (11.42) 18.10 (8.96) 13.90 (7.54)
C-reactive protein (mg/l)d 240 (123) 183 (58) 216 (84) 254 (117) 198 (116)
Creatinine (µmol/l)e 165 (124) 86 (8) 157 (106) 154 (110) 151 (108)
Sodium (mmol/l) 134 (5) 140 (6) 134 (7) 136 (4) 134 (4)
Glucose (mmol/l)f 10.9 (6.7) 9.1 (3.6) 12.8 (8.3) 12.4 (5.1) 10.5 (4.4)
Physiological values
Pulse (beats/minute)g 112 (22) 95 (19) 135 (28) 107 (21) 107 (25)
Mean arterial pressure (mmHg)g 60 (8) 59 (4) 63 (4) 59 (8) 57 (12)
LRINEC scoreh 7.3 (2.7) 6.0 (3.1) 7.0 (3.4) 7.5 (2.4) 7.7 (3.1)
Data are the mean (s.d.) from 148 patients. Laboratory and physiological values pertain to the first 24 hours after ICU admission. For hemoglobin and sodium, the lowest recorded values are indicated.
For white blood cells, C-reactive protein, creatinine and glucose, the highest recorded values are indicated. For pulse, the highest value is indicated whereas for mean arterial blood pressure, the lowest
value is indicated. The LRINEC score includes sub scores ranging from 0 to a maximum of four for six different blood samples (hemoglobin, white blood cells, C-reactive protein, creatinine, sodium, and
glucose). Aggregated scores range from 0 to 13, with higher scores indicating higher risk of necrotizing fasciitis
LRINEC Laboratory Risk Indicator for Necrotising Fasciitis
aIncluding patients who were primarily admitted for other reasons. Data regarding exact time of initial hospital admission were missing for three patients in the streptococcal group, one patient in the
staphylococcal group and one patient in the polymicrobial group
bData for hemoglobin were missing for one patient in the streptococcal group
cData for white blood cells were missing for one patient in the streptococcal group
dData for CRP were missing for three patients in the streptococcal group and for two patients in the polymicrobial group
eData for creatinine were missing for one patient in the streptococcal group
fData for glucose were missing for three patients in the streptococcal group for one patient in the polymicrobial group
gData for pulse and mean arterial pressure were missing for one patient in the polymicrobial group
hData for the LRINEC score were missing for 13 patients in the streptococcal group, for seven patients in the polymicrobial group and for three patients in the others group
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(GO:0016485) predominated in the transcriptional profile of the
bacteria associated with polymicrobial NSTIs (Fig. 3, Supple-
mentary Data 5). Furthermore, lipopolysaccharide core region
biosynthesis (GO:0009244), lipid A biosynthesis (GO:0009245),
and polysaccharide transport (GO:0015774), all of which are
involved in the synthesis and transport of lipopolysaccharide
(LPS) were significantly enriched in the functional profile of
polymicrobial NSTIs (Fig. 3, Supplementary Data 5). This
expression of LPS, the integral component of the outer mem-
brane of Gram-negative bacteria and powerful activator of a
robust inflammatory response, may contribute to the inflam-
matory response observed in polymicrobial NSTIs.
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Due to their generally commensal lifestyle, the pathogenic
mechanisms expressed by the bacterial species identified in
polymicrobial NSTIs are severely understudied. To overcome this
limitation, we assessed the pathogenic potential of pathobionts in
polymicrobial NSTIs by querying the bacterial expression profiles
for conserved virulence-associated protein domains, using the
InterProScan tool (see Materials and Methods, Supplementary
Data 6). To enable comparison between mono- and polymicrobial
Fig. 1 Single pathogens as well as complex bacterial communities can cause severe NSTIs. a Bacterial composition in tissue biopsies (n= 148) from
patients with NSTIs. Bacterial genera with a mean relative abundance of ≥2.5% across all samples or a maximal relative abundance of ≥80% are depicted.
The Gini–Simpson diversity index shows genus-level diversity. b Co-occurrence network of the 18 genera with the highest mean relative abundance across
all samples. Dark edges illustrate co-occurrence, light edges mutual exclusion (Brown’s p-value ≤0.05). Outer lines represent distinct bacterial clusters
(see Supplementary Figure 8). c Bacterial community diversity and structure in NSTI biopsies depicted against the affected body part. The bacterial
community diversity is given to the top where each dot represents the Gini–Simpson diversity index from one specimen. Lines represent median values.
Diversity indices across the five body parts (n= 14, 18, 12, 23, and 37, respectively from left to right) were compared using the Kruskal–Wallis test with
Dunn’s multiple comparison post hoc test with ***p < 0.001; *p < 0.05. The bacterial community structure is indicated to the bottom where bars depict the
mean relative abundance of genera at each body site. The color code depicting the different genera is as given in a. For statistical evaluation of the relative
abundance of genera at different body sites see Table 2. Source data are provided in Supplementary Data 1, 2, 3, and 4
Table 2 Genera are differently abundant at affected body sites
U/L U/H U/A U/T L/H L/A L/T A/H T/H A/T
Streptococcus ns ns ns ns ns 0.0128 ns ns ns ns
Bacteroides ns ns 0.0018 ns ns 0.0308 ns ns ns ns
Parvimonas ns 0.0004 ns 0.0352 0.0071 ns ns ns ns ns
Prevotella ns <0.0001 0.0038 ns 0.0029 ns ns ns ns ns
Porphyromonas ns 0.0022 0.0052 ns 0.0271 ns ns ns ns ns
Peptostreptococcus ns 0.0141 ns ns 0.0093 ns ns ns ns ns
Escherichia/Shigella ns ns ns 0.0292 ns ns ns ns ns ns
Fusobacterium ns 0.0015 ns ns 0.0245 ns ns ns ns ns
Eggerthia ns 0.0164 ns ns 0.0039 ns ns 0.0479 ns ns
Eubacterium ns 0.0016 ns ns ns ns ns 0.0435 ns ns
Solobacterium ns 0.0001 ns 0.0033 0.0045 ns ns 0.0141 ns ns
Dialister ns 0.0002 0.0044 ns 0.0011 0.0257 ns ns ns ns
Bulleidia ns 0.0022 ns ns 0.0171 ns ns 0.0310 ns ns
Filifactor ns 0.0343 ns ns 0.0286 ns ns 0.0316 ns ns
Atopobium ns 0.0004 ns ns 0.0034 ns ns ns 0.0019 ns
Alloprevotella ns 0.0005 ns ns 0.0027 ns ns 0.0050 ns ns
Pseudoramibacter ns 0.0231 ns ns 0.0273 ns ns ns ns ns
Campylobacter ns ns 0.0004 ns ns 0.0338 ns ns ns ns
Olsenella ns 0.0208 ns ns ns ns ns ns ns ns
Oribacterium ns <0.0001 ns ns <0.0001 ns ns 0.0089 ns ns
Abundances at different sampling sites (U, upper extremities; L, lower extremities; H, head/neck; A, anogenital region; T, thorax/abdomen) were compared using the Kruskal–Wallis test with Dunn’s
multiple comparison post hoc test (n= 104). Given are genera, which significantly differed in abundance at at least one sampling sites (p < 0.05). p-values > 0.05 are indicated by ns (non significant). In
most cases, genera are of a significantly higher abundance at the later mentioned body site. Cases where genera are of a lower abundance at the later mentioned body site are indicated with bold numbers
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NSTIs, the same method was applied to characterized virulence
factors expressed by Streptococcus spp. in monomicrobial NSTIs.
Using this approach, we observed that genes encoding
prominent virulence factors with well-defined roles in the
pathogenesis of Streptococcus spp. during NSTI were highly
expressed during NSTI (Fig. 4a, b). In contrast, expression of a
greater diversity of virulence-associated domains was evident in
polymicrobial NSTIs, reflecting the underlying diversity of the
bacterial community (Fig. 4a). Functional aggregation of the
identified protein domains indicated that factors mediating
adhesion/invasion, immune evasion, proteolysis, and toxin
activities contribute to the pathogenicity of Streptococcus spp. in
monomicrobial NSTIs, while only domains associated with
factors mediating cellular adhesion and extracellular proteolytic
activity were highly expressed by the bacterial communities
associated with polymicrobial NSTIs (Fig. 4c, d).
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Fig. 3 Streptococcus spp. and polymicrobial communities express different functionalities that facilitate nutrient acquisition and sustained inflammation. GO terms
(root: biological process) with significantly higher associated gene expression in the transcriptional profile of Streptococcus spp. (red, n= 17) or polymicrobial
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Interestingly, cellular adhesion, which facilitates tissue coloni-
zation and successful establishment of infection, was mediated by
different mechanisms in monomicrobial Streptococcus spp. and
polymicrobial NSTIs. For example, factors mediating adhesion to
collagen and other extracellular matrix (ECM) components,
known to be relevant for colonization of various host
environments including commensal niches20, were highly
expressed by the polymicrobial pathobiome (Fig. 4e). On the
other hand, expression of genes encoding fibronectin-binding
proteins (sfbII, prtF1, prtF2, fbp54), which mediate not only
adherence to ECM but also bacterial invasion into host cells21,
was pronounced in the transcriptional profile of Streptococcus
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spp. (Fig. 4a, b, e). Similarly, while genes encoding a broad array
of proteolytic factors were strongly expressed in both types of
NSTIs, differences in the relative abundance of the protease
families indicate that different proteolytic activities are exploited
by Streptococcus spp. in monomicrobial NSTIs and the human
pathobionts in polymicrobial NSTIs (Fig. 4f).
Importantly, during polymicrobial NSTIs different members of the
polymicrobial community contributed to the expression of specific
virulence functionalities to a different extent (Fig. 4g). Thus,
Porphyromonas spp., which has been shown to express potent
proteases in the oral cavity22, contributed strongly to the proteolytic
potential of the community, while Parvimonas spp., Fusobacterium
spp., and Peptostreptococcus spp. were responsible for the majority of
the expression mediating the adhesive properties of the pathobiome.
These observations indicate that bacterial synergism may contribute
to the pathogenicity in polymicrobial NSTIs.
Host response differs in streptococcal and polymicrobial
NSTIs. The transcriptional analysis of infected tissue indicated that
the gene expression profile differed significantly between mono-
microbial Streptococcus spp. (n= 17) and polymicrobial (n= 22)
NSTIs (PERMANOVA, p-value= 0.001), (Supplementary Figure 11,
Supplementary Table 2). Nevertheless, a core acute inflammatory
signature comprising genes encoding important inflammatory
mediators, including cytokines (IL-1β, IL-6, IL-8), complement
components (C1q, C2, C3, C5), alarmins (S100A8/9), genes encoding
a range of factors with broad proteolytic activities (ADAM8, 10, 12,
15, 17, 19, 28, ADAMTS2, 4, 5, 6, 9, 12,MMP2, 3, 8, 10, 12, 13, 15, 24,
25) and hypoxia responsive genes (HIF1A, ENO1, BHLHB2, BINP3,
PHHA1, LDHA, GAPDH) was observed in both mono- and poly-
microbial NSTIs (Supplementary Data 7, 8). Among the genes with
significantly greater expression in polymicrobial compared to
monomicrobial NSTIs were those encoding ECM components like
collagen, fibronectin or lumican, as well as connective tissue growth
factor (CTGF) (Fig. 5a, b, Supplementary Data 8), proteins which are
commonly expressed by activated fibroblasts23. On the other hand, a
set of genes encoding interferon-inducible mediators such as CXCL9,
CXCL10, CXCL11, MX1, and MX2 as well as the guanylate-binding
GTP1 and GTP2 were most prominently higher expressed in
monomicrobial NSTIs, in particular those caused by S. pyogenes
(Fig. 5a, Supplementary Data 8).
Potential biomarkers for the diagnosis of S. pyogenes NSTIs.
To determine if the differences in interferon-inducible gene expres-
sion observed between streptococcal and polymicrobial NSTIs
biopsies were also detectable at the protein level, a panel of
interferon-related mediators including IFN-alpha, IFN-beta, IFN-
gamma, IFN-lambda, IL-6, IL-8, IL-1beta, IL-10, TNF-alpha, GM-
CSF, IL-28, CXCL9, CXCL10, and CXCL11 was measured in plasma
samples of a set of NSTIs patients (training cohort) at the time of
hospital admission. This training cohort consisted of 12 mono-
microbial S. pyogenes NSTI patients, 22 polymicrobial NSTI patients
as well as five healthy control subjects (Supplementary Data 3). Of
these proteins only CXCL9, CXCL10, and CXCL11 displayed sta-
tistically significant concentration differences between S. pyogenes
and polymicrobial NSTIs (Fig. 6, Supplementary Figure 12).
Prompt diagnosis of group A streptococcal NSTIs is of
outmost clinical importance, as these infections are frequently
associated with high systemic toxicity, requiring rapid interven-
tion to halt disease progression. Therefore, we assessed the
potential use of host-derived signatures for microbial diagnosis
of NSTIs caused by S. pyogenes. We compared the ability of three
different modeling techniques (logistic regression, linear support
vector machine and random forest classifier) to discriminate
between S. pyogenes and non-S. pyogenes NSTIs based on the
plasma concentrations of the measured protein-panel. The
random forest classifier outperformed the other two approaches
in the training cohort, achieving a mean area under the receiver
operatoring characteristic curve (ROC-AUC) of 0.954 (Fig. 7a)
and was therefore adopted for further analysis. Because in
clinical practice it is desirable to keep the number of parameters
required for diagnosis to a minimum and a reduction of feature
space can also reduce model overfitting and improve perfor-
mance, we applied the BORUTA algorithm to identify the most
relevant features in the classification model. The algorithm
identified the plasma concentrations of CXCL9, CXCL10 and
CXCL11 as relevant for identification of the different types of
NSTIs (Fig. 7b). The discriminatory power of a model trained
only on these three parameters (3-feature model) was compared
with that of the all-features model. The 3-feature model achieved
a mean ROC curve AUC of 0.95 showing comparable
performance to the full model (Fig. 7c). The potential of these
plasma biomarkers for the identification of S. pyogenes NSTIs
was then tested in an independent set of patients (n= 59), of
which 27 were identified by 16S rRNA gene sequencing as
monomicrobial S. pyogenes NSTIs and 32 as NSTIs caused by
microorganism(s) other than S. pyogenes (Supplementary Data 3).
We confirmed significantly higher plasma concentrations of
CXCL9, CXCL10, and CXCL11 in S. pyogenes NSTI patients
compared to NSTIs cases of other microbial etiology (Supple-
mentary Figure 13). When tested in this independent cohort, the
trained 3-feature random forest model achieved a ROC-AUC of
0.822 (Fig. 7d) and was able to correctly classify 21 of 32 non-S.
pyogenes and 23 of 27 S. pyogenes NSTIs patients (Fig. 7e). Thus,
while the model had a relatively high error rate in classifying
non-streptococcal NSTIs, it exhibited promising performance in
identifying S. pyogenes NSTIs (True Positive Rate 85%), high-
lighting the potential of a limited panel of host-derived
biomarkers for rapid identification of S. pyogenes NSTIs allowing
early therapeutical intervention.
Fig. 4 Different virulence functionalities contribute to the pathogenicity of Streptococcus spp. and polymicrobial communities during NSTIs. a Summed mean
expression level (log2 TPM± s.d.) of genes categorized based on their encoded InterPro (IPR) domains. The relative contribution of documented streptococcal
virulence genes to IPR domain expression is depicted on the bars (left). The log2 differences in IPR expression between Streptococcus spp. (red, n= 17) and
polymicrobial community (blue, n= 22) mediated NSTIs are depicted in the center. Gray bars mark IPR domains expressed by only one pathobiome and were
calculated assuming one pseudo-TPM. b Streptococcal virulence factor expression (TPM) during NSTIs. The expression level is given for virulence-associated
genes annotated using the virulence factor database (VFDB). c, d IPR domain expression associated with specific virulence categories. Average total abundances
(TPM± s.d.) (c) and relative expression levels of virulence categories (d) are given. e, f Relative proportion of InterPro domain expression in the functional
categories ‘adhesion’ (e) and ‘proteolysis’ (f) associated with terms indicating target specificity (e) or protease class (f). Putative adhesins and unclassified
proteases are depicted in gray. ***p <0.001; **p <0.01; *p<0.05, Kruskal–Wallis test with Dunn’s multiple comparison post hoc test (n= 39). g Contribution of the
five genera with the highest average abundances in polymicrobial NSTIs to the total pathobiome expression of specific virulence categories. The relative amount of
transcripts (TPM) expressed by each genus is plotted against the relative amount of transcripts encoding IPR domains involved in adhesion (top) or proteolysis
(bottom). Squared correlation coefficients are depicted. Source data are available as a source data file
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Discussion
It is well documented that NSTIs, besides being monomicrobial in
nature and caused by professional pathogens, can also be caused
by polymicrobial bacterial communities1,7. However, despite the
fact that these polymicrobial infections often outnumber those of
monomicrobial etiology, there is a lack of information regarding
their bacterial composition and activities. Culture-dependent
analysis of polymicrobial NSTIs remains generally restricted to
the most abundant or easily culturable bacteria8. Amazingly, to
date, only a single study has attempted to analyze the microbial
composition in NSTIs using a 16S rRNA gene sequencing
approach. This study, performed in a limited cohort of 10
volunteers, showed that standard cultivation methods under-
estimate the diversity of the complex bacterial communities in
polymicrobial NSTIs24. In the study presented here, we used 16S
rRNA gene sequencing to analyze the bacterial communities
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associated with NSTIs in a cohort of 148 patients and could
demonstrate that polymicrobial communities in NSTIs are not
randomly associated, but typically comprised of co-occurring
bacteria forming a highly interconnected network. The bacterial
genera dominating in polymicrobial NSTIs, which include Por-
phyromonas spp., Fusobacterium nucleatum and Prevotella spp.
(Fig. 1a, b, Supplementary Figure 8a) have been shown to
synergistically interact in an in vitro model of chronic period-
ontitis25 as well as in suppurative apical periodontitis in a murine
infection model26. Hence, their co-occurrence during NSTIs
might suggest that similar interactions facilitate tissue coloniza-
tion and drive disease progression. Overall, these analyses refute
the statement of Rudkjøbing et al. that there are no specific
combinations of species in polymicrobial NSTIs24. Although
several of the species that we identified in polymicrobial NSTIs,
such as Prevotella intermedia or Parvimonas micra, have pre-
viously been recovered from other bacterial infections27,28, they
are also common members of the healthy human microbiota29.
This observation indicates that the contribution of these micro-
organisms to the overall NSTIs burden is most probably still
underestimated in the clinical setting as culture-based methods
frequently fail in their detection24,30. Furthermore, the changing
microbial epidemiology of NSTIs observed over the last decades31
is also apparent in our study. Clostridium sensu stricto were only
observed in rare instances, a trend that has been linked to
improvements in hygiene and sanitation conditions32.
The results of the community profiling support the previously
reported prominent role of S. pyogenes in the microbiology of NSTIs7
as well as the high frequency of streptococcal NSTIs reported in
Scandinavia5. The pathophysiology of S. pyogenes NSTIs has been
extensively explored and many of the underlying pathogenic
mechanisms previously described10,33 are supported by our results.
Thus, robust expression of adhesion factors such as fibronectin-
binding proteins34, of factors that enable the bacterium to circumvent
the host immune response such as streptococcal inhibitor of com-
plement (Sic), streptococcal C5a peptidase (ScpA)35, and streptolysin
O36, as well as of important extracellular proteases such as SpeB37
were observed. Adjunct treatment strategies to neutralize some of
these factors such as IVIG therapy, which consist of pooled immu-
noglobulins from human donors have been suggested to limit
destructive hyperinflammatory responses in NSTIs2,38. Although
IVIG may be beneficial for treatment of S. pyogenes NSTIs39, there is
no evidence that it can provide therapeutic benefit for polymicrobial
NSTIs40. Hence, there is a need for new therapeutic approaches that
can be given as adjunct therapy for the treatment of polymicrobial
NSTIs. In this study, we performed dual RNASeq analysis of human
tissue biopsies to gain a more in-depth understanding of the
microbial and molecular pathogenesis of NSTIs and to uncover
targets for novel treatment strategies. While characterization of the
metabolic activity and virulence of S. pyogenes in NSTIs was facili-
tated by the substantial existing knowledge about its pathogenicity
mechanisms, the lack of a reference database of pathogenic factors for
several bacteria identified in polymicrobial infections presented a
significant limitation for this analysis. To overcome this limitation,
we characterized the bacterial gene expression profile using conserved
protein domains. We observed that, in contrast to Streptococcus spp.
which rely on non-glucose carbohydrates metabolism as previously
reported41,42, the expression of genes encoding factors that contribute
to amino acid transport and metabolism, as well as peptidolysis were
strongly expressed by the polymicrobial communities. This suggests
that nutrient acquisition by these bacteria might heavily rely on
proteolytic degradation of host proteins as shown for some of the
most abundant bacterial genera in polymicrobial NSTIs, Fuso-
bacterium spp., Prevotella spp., and Porphyromonas spp., during
periodontitis in the oral cavity43. Interestingly, we observed that
Porphyromonas spp. contributed disproportionately to the proteolytic
potential of the microbial community. This observation supports the
theory that synergistic complementation of specialized bacteria might
be critical for establishment and progression of polymicrobial NSTIs.
Additionally, a robust expression of genes coding for factors that
contribute to lipopolysaccharide (LPS) synthesis was observed in
polymicrobial NSTIs biopsies. This integral component of the outer
membrane of Gram-negative bacteria is a powerful activator of
inflammation in the human skin and the underlying tissues44 and
neutralization of LPS may provide an adjunct therapeutic strategy to
decrease inflammation-induced pathology in polymicrobial NSTIs.
Because of the rapid disease progression, early diagnosis of NSTIs
is critical to limit patient morbidity and mortality. Such a diagnosis,
however, frequently proves to be challenging as symptoms can be
ambiguous and frequently overlap with other clinical entities. Most
prominently, the LRINEC score, comprising plasma concentrations
of serum leukocytes, glucose, sodium, C-reactive protein (CRP),
creatinine, and hemoglobin, has been developed to facilitate early
diagnosis and limit time to surgical intervention45. Importantly,
LRINEC scores did not differ between streptococcal and poly-
microbial infections in our cohort and times from hospital admission
to surgery were comparable (53 ± 114 (mean ± s.d, n= 73) for
streptococcal and 33 ± 56 (n= 45) hours for polymicrobial infections,
Table 1). As recent work has questioned the diagnostic value of
frequently used clinical parameters46 and ultimate diagnosis can only
be achieved by surgical exploration1, diagnostic uncertainty of disease
onset frequently hampers accurate early detection of NSTIs. This can
lead to patients with variable stages of the disease being admitted to
intensive care units, making prompt and accurate microbial diagnosis
crucial to effectively halt disease progression. Guidelines for the
management and treatment of NSTIs involve surgical debridement of
the affected area combined with empiric high-dose intravenous
broad-spectrum antibiotics to cover all potential pathogens that can
cause NSTIs11. Antibiotic coverage can be narrowed once the cau-
sative microorganism(s) have been identified. For this reason, many
NSTIs patients receive unnecessary or inappropriate antibiotics,
which could be prevented by earlier identification of the causative
pathogen(s). Therefore, the use of biomarkers that can distinguish
between different types of NSTIs has the potential to reduce the time
of broad-spectrum empirical therapy and to improve the patient
outcomes by early administration of effective antibiotics. The com-
parative transcriptional profiling of NSTI tissue biopsies performed in
this study uncovered interferon-related mediators, in particular type I
interferon, associated with S. pyogenes NSTIs. This type I interferon
response has been reported to be expressed by the host in response to
S. pyogenes in order to reduce tissue damage caused by hyper-
inflammation47. We also observed significantly greater concentra-
tions of the interferon-inducible chemokines CXCL9, CXCL10, and
CXCL11 in the circulation of S. pyogenes NSTIs patients than in
circulation of patients with polymicrobial NSTIs. The potential value
of these chemokines as biomarkers of S. pyogenes NSTIs was shown
by a random forest model trained on the plasma concentrations of
these three chemokines followed by validation in an independent
patient cohort. The results of this exploratory analysis identified
plasma concentrations of CXCL9, CXCL10, and CXCL11 as being
potentially useful biomarkers for microbial diagnosis of S. pyogenes
NSTIs (85.2% true positive rate). While the classifiers showed a
relatively high error rate when classifying non-S. pyogenes NSTIs
(34.4%), early differentiation of NSTIs caused by S. pyogenes from
those of different bacterial etiology is of outmost clinical importance
as S. pyogenes NSTIs are generally associated with high systemic
toxicity and require prompt intervention. Thus, interferon-induced
chemokines show specific promise for the identification of patients
requiring rapid ajunct therapies such as IVIG treatment39. The
classifier performance may be improved in future studies that test a
broader panel of plasma markers. Genes identified as differentially
expressed between streptococcal and polymicrobial NSTIs in this
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study might serve as a starting point to achieve higher classification
accuracy via the inclusion of additional features in a classification
model.
Following identification of a robust set of biomarkers, the
challenge for the validation phase will be to develop suitable
analytical methods capable for the fast quantification of the
identified biomarkers. In this regard, microfluidic immunoassay
systems in miniaturized devices that require small reagent
volumes and very short analysis time may be a good option for
generating such a NSTIs point-of-care diagnostic test. Several
systems have been recently described combining microfluidics
with detection of magnetic bead-based immunoassays for mea-
surements in less than 1 h48,49. The multiplex microfluidic array
designed by Malhotra et al.48, for example, was able to detect four
biomarker proteins in patient serum with high sensitivity and
accuracy. We envisage a similar device for detection of CXCL9,
CXCL10, CXCL11 or other host-derived biomarkers that could
provide a rapid point-of-care serum test for microbial diagnostic
and personalized therapy of NSTIs patients.
Taken together, our results demonstrate that despite similar
clinical presentation, the pathophysiology of NSTIs caused by S.
pyogenes or by polymicrobial communities differs significantly
and that these differences can be eventually exploited for treat-
ment and diagnostic purposes.
Methods
Study design. This study was designed to identify the bacterial taxa associated with
NSTIs, identify their functionalities that contribute to disease pathophysiology and
identify host signatures of potential value for rapid microbial diagnosis at the time
of hospital admission. Tissue biopsies and plasma samples were obtained from
patients clinically diagnosed with NSTIs and enrolled in the EU-funded project
INFECT (www.fp7infect.eu). Diagnosis of NSTIs was performed by the acting
surgeon at primary operation or revision as described earlier50. Briefly, diagnosis
was based on the presence of necrotic or deliquescent soft tissue with widespread
undermining of the surrounding tissue. Following initial diagnosis, patient files and
surgical descriptions were again scrutinized and patients were excluded from the
study if reports of necrotic or deliquescent tissue were absent. All remaining
patients were eligble to be included in this study. Written informed consent was
obtained from all patients or their surrogate. The INFECT study is registered at
ClinicalTrials.gov (NCT01790698). The INFECT study was conducted in accor-
dance with the Declaration of Helsinki and with the approval of the regional
Ethical Review Board at the Karolinska Institutet in Stockholm, Sweden (Ethics
permits: 2012/2110-31/2), the National Committee on Health Research Ethics in
Copenhagen, Denmark (Ethics permits: 1151739), the regional Ethical Review
Board in Gothenburg, Sweden (Ethics permits: 930-12) and Bergen, Norway (2012/
2227/REC West). Specimens from patients admitted to five Scandinavian hospitals,
Righospitalet (Copenhagen, Denmark), Karolinska University Hospital (Stock-
holm, Sweden), Blekingesjukhuset (Karlskrona, Sweden), Sahlgrenska University
Hospital (Gothenburg, Sweden), and Haukeland University Hospital (Bergen,
Norway), were included in this study. All experiments were performed in full
accordance with the approved ethics applications specified above. Patient mortality
was recorded for a period of 365 days following study enrollment. The level of
hemoglobin, white blood cells, C-reactive protein, creatinine sodium, and glucose
in blood, patient pulse and mean arterial pressure were determined at hospital
admission. Time from hospital admission to surgery was recorded for all patients.
Only tissue samples taken on the day of hospital admission (day 0) were included
in this study to enable the identification of robust host signatures indicative of
bacterial etiology irrespective of time since onset of initial symptoms. Specimens
for 16S rRNA gene sequencing (148) were randomly selected from patients with
available day 0 tissue biopsies. All tissue biopsies were obtained intraoperatively
and stabilized with RNAlater™ (Thermo Fisher Scientific).
Sample pre-processing. Stabilized tissue was transferred into 1 ml TRIzol™
(Invitrogen) reagent containing 50 µl of vanadyl ribonucleoside complex (VRC)
and mechanically disrupted using a Polytron disperser (Kinematica). To achieve
optimal bacterial lysis, samples were transferred into lysing matrices B (MP Bio-
medicals) and disrupted using a FastPrep-24® (MP Biomedicals). Tissue debris was
removed by centrifugation and phase separation was achieved by addition of 200 µl
Chloroform (Carl Roth) followed by centrifugation. The aqueous phase containing
total RNA was separated for subsequent RNA purification, while the interphase
and organic phase were used for further DNA purification.
16S rRNA gene preparation and sequencing. The DNA was purified following
the manufacturer’s protocol for TRIzol™ DNA extraction (Thermo Fisher
Scientific). Amplicon libraries of the V1-V2 region of the 16S rRNA gene were
generated as previously described51. The target region was amplified by PCR fol-
lowing 20 cycles of PCR reaction using the 27F and 338R primers and sequenced
on a MiSeq platform (2 × 250 bp)51.
Bioinformatic analysis of the NSTI-associated microorganisms. A total of
4,593,685 reads were generated, resulting in 31038 ± 18665 reads per sample.
Bioinformatic processing was performed as previously described51. Raw reads were
merged with the Ribosomal Database Project (RDP) assembler. Sequences were
aligned within MOTHUR (gotoh algorithm using the SILVA reference database)
and subjected to preclustering (diffs= 2) yielding phylotypes that were filtered for
an average abundance of ≥0.001% and a sequence length ≥250 bp before analysis
(Supplementary Data 1). Phylotypes were assigned to a taxonomic affiliation based
on naïve Bayesian classification with a pseudo-bootstrap threshold of 80%. Phy-
lotypes were then manually analyzed against the RDP database using the Seqmatch
function to define the discriminatory power of each sequence type. Species level
annotations were assigned to a phylotype when only 16S rRNA gene fragments of
previously described isolates of a single species were aligned with a maximum of
two mismatches with a representative sequence read. Similarly, genus-level anno-
tations were assigned to a phylotype when only the representative sequence aligned
to isolates and uncultured representatives of a single genus with up to two
mismatches.
For additional taxonomic characterization, the identified Streptococcus spp.,
Prevotella spp., Porphyromonas spp., Bacteroides spp., Fusobacterium spp., and
Peptostreptococcus spp. sequences were compared to sequences of all isolates with
species level annotation available in RDP (release 11 update 5). Isolate sequences
were aligned with MUSCLE52 and edited using SEAVIEW53. Sequences were
trimmed to the V1–V2 region and all sequences of poor quality (≥1 N
per sequence) as well as those not completely covering the amplified region were
deleted.
To reduce complexity, unique Streptococcus sequences assigned to only a single
isolate with species level annotation were removed before phylogenetic analysis.
Phylogenetic analyses were performed using the neighbor joining routine with
Jukes–Cantor correction and pairwise deletion of gaps in MEGA754. Species names
were assigned to phylotypes that clustered with sequences of only a single species,
were supported by high bootstrap values >50% and exhibited >97.5% of sequence
identity to a reported sequence of a species representative. Phylotype data were
rarified to resemble the smallest library size using the R phyloseq package
(Supplementary Data 2) and used to construct sample-similarity matrices using the
Bray–Curtis algorithm (V.7.0.11, PRIMER-E, Plymouth Marine Laboratory, UK).
Bacterial alpha-diversity was calculated using the Gini–Simpson index (1-Λ) on
rarified phylotype data.
NSTIs were classified according to the body part affected on admission into five
categories: Head/neck, upper extremities, lower extremities, anogenital, and thorax/
abdomen. Cases that had multiple body parts affected were excluded from the
analysis. Significant differences between these five a priori defined groups of
samples were evaluated using the permutational multivariate analysis of variance
(PERMANOVA), allowing for type III (partial) sum of squares, fixed effects sum to
zero for mixed terms and the generation of Monte Carlo p-values using
unrestricted permutation of raw data. Phylotype and genera abundance as well as
diversity indices across the five body parts were compared using the
Kruskal–Wallis test with Dunn’s multiple comparison post hoc test and were
assumed to be significantly different if p-value ≤ 0.05.
Bacterial co-occurrence modeling and specimen classification. To identify
patterns of bacterial co-occurrence an ensemble method implemented within the
Cytoscape application CoNet, optimized for sparse datasets, was applied to
column-wise normalized phylotype counts aggregated at the genus level17. To
avoid misinterpretation resulting from sparse data, genera present in less than 25%
of all samples were excluded prior to the modeling step. Two measurements of
correlation between genera (Spearmen and Pearson) and two dissimilarity mea-
surements (Kullback–Leibler and Bray–Curtis) were used to compute scores for
genera interactions (network edges) ignoring parent-descendant relationships.
Statistical significance was assigned to the resulting edge scores following
measurement-specific permutation and bootstrapping with 999 iterations each. To
counter the compositionality bias of correlation measures inferred from column-
wise normalized data, a re-normalization approach that provides a null-
distribution and captures the similarity introduced by compositionality was applied
during the permutation step17. P-values of correlation measurements were calcu-
lated by z-scoring the permuted null and bootstrap confidence interval using
pooled variance. In contrast, p-values of the dissimilarity measurements were
computed by comparing the bootstrap confidence interval to a point null value
computed by permutation, as they are inherently robust against compositionality55.
The resulting measurement-specific networks were merged using Brown’s method
for p-value combination56 and adjusted for multiple comparisons using the
Benjamini–Hochberg correction. Phylotype interactions with adjusted p-values ≤
0.05 and supported by at least two independent methods were retained in the final
model (Supplementary Data 3). Distinct NSTI-associated bacterial communities
were identified through divisive graph clustering of co-occuring genera using the
Markov cluster algorithm (MCL)57 with an inflation of 1.5 retaining modest
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network granularity (Supplementary Figure 8a). The Markov clustering (MCL)
algorithm was chosen as it has been successfully applied to a variety of biological
datasets (microbiome data, gene networks, protein–protein interaction networks)
and frequently outperforms other clustering algorithms58. Patients were classified
into distinct types of NSTIs based on average-linkage hierarchical agglomerative
clustering using the relative abundance of the identified bacterial communities
(Fig. 2a). The optimal number of clusters in the resulting sample dendrogram was
determined using the J-index59 and distinct specimen clusters were defined to
represent different types of NSTIs.
RNA-seq sample preparation and sequencing. Total RNA was extracted using
the TRIzol™(Thermo Fisher Scientific) reagent according to the manufacturer’s
recommendations and DNA contamination was removed by DNase treatment
using four U Turbo DNase™ (Ambion). RNA integrity was controlled on an Agilent
2100 Bioanalyzer (Agilent Technologies). ERCC RNA Spike-In Mixes (Thermo
Fisher Scientific) were added to individual samples according to the manufacturer’s
guidelines for later determination of the lower limit of detection and to control for
technical derived errors in the datasets. Ribosomal RNA was depleted using the
RiboZero epidemiology kit (Illumina) according to the manufacturer’s recom-
mendations. cDNA libraries were prepared using the ScriptSeq v2 RNA-seq Library
Preparation Kit (Illumina) according to the manufacturer’s instructions. Libraries
were size-selected between 250 and 1000 bp using BluePippin (Sage Science) fol-
lowing the manufacturer’s protocol. Library quality and size-selection was con-
trolled using an Agilent 2100 Bioanalyzer (Agilent Technologies). The cDNA
libraries were sequenced (1 × 50 bp) on the Illumina HiSeq 2500 platform to a
maximum depth of 143.8 million reads using the TruSeq S.R. Cluster Kit, v3-cBot-
HS (Illumina). Samples were exluded from further analysis if (1) the integrity of the
isolated total RNA was low (RIN value < 4) or (2) the proportion of bacterial reads
did not allow robust analysis of the generated dataset.
Bioinformatic analysis of RNA-seq data. Following demultiplexing and trim-
ming, raw reads were pseudoaligned to the human genome assembly GRCh38.p10
using kallisto60 and unaligned reads were stored for further bacterial metatran-
scriptome analysis. Human transcript based pseudoalignments were summarized at
the gene level for later differential gene expression analysis using the R package
tximport61. To eliminate potential confounding effects associated with variability in
sample collection in a multi-center cohort study, unsupervised surrogated variable
analysis was used to identify potential nuisance factors uncorrelated with the
experimental factor of interest using the R package SVA62. Identified nuisance
factors were included as covariates in downstream analysis. The R package
DESeq263 was used to identify human genes that were differentially expressed
between tissue biopsies from patients infected with Streptococcus spp. mono-
infections and biopsies from patients with polymicrobial NSTIs. Significant nui-
sance factors identified by surrogate variable analysis were included as covariates in
the design formula of the differential gene expression analysis. A gene was con-
sidered significantly differentially expressed if the Benjamini–Hochberg adjusted p-
value ≤ 0.05. GO enrichment analysis was performed on all genes with significantly
different transcript abundance using DAVID Informatics Resources64. Gene
Ontology (GO) categories were considered significantly enriched in one infection
type if the Benjamini–Hochberg adjusted p-value was ≤0.05. The functional rela-
tionship of significantly enriched GO terms was inferred from network analysis
using EnrichmentMap65. Network edges were calculated using the overlap coeffi-
cient implemented in the package routine (threshold ≥0.4). Clusters of functionally
related GO terms were identified by hierarchical clustering using the hierarchical
clustering algorithm in protein interaction networks (HC-PIN, strong module
definition, complex size threshold= 3) implemented in the CytoCluster package66.
Absolute counts for each gene and each sample were then transformed into
standard z-scores by subtracting the mean expression of a gene across all samples
from the absolute counts in an individual sample and dividing this value by the
standard deviation of the absolute counts of this gene across all samples.
Guided by the 16S rDNA amplicon analysis, genus-specific transcriptomes were
compiled for all genera with a relative abundance ≥ 2% in at least one of the
analyzed samples. Genus specific metatransriptomes were compiled from all
available assemblies in the RefSeq database up to a maximum of n= 250 and
including assemblies in a quality dependent hierarchical order: first complete
genomes, thereafter chromosomes, scaffolds, and contigs (assessed August 2017).
For each genus, assemblies were randomly selected if more than 250 genomes were
available and lower quality assemblies (chromosomes, scaffolds, contigs) were only
considered if the number of available genus genomes was ≤200 (Supplementary
Data 9). Based on the genus composition of each specimen, sample-specific
reference databases were created by concatenating the metatranscriptomes of all
genera present with a relative abundance ≥2%. Reads that did not align to the
human genome were pseudoaligned to their respective indexed reference using
kallisto. Genes with low expression level (<11 counts in any sample) were excluded
before downstream analysis. Redundant genes from different genomes, which were
identified by matching NCBI RefSeq protein IDs, gene lengths and pseudoaligned
read counts, were considered for further analysis. Genes were annotated (KEGG,
GO, PFAM and InterPro) using InterProScan 5 (RC 1). Genus-specific
functionality profiles were constructed by clustering translated gene sequences
applying the UniRef50 parameters using BLAST (e-value ≤ 1 × 10–6, sequence
identity ≥ 50%, coverage ≥ 80%), obtaining clusters of homologous genes67.
Estimated counts, InterPro and NCBI annotations were aggregated for each gene
cluster. The expression of each cluster of homologous genes was expressed as
transcripts per million (TPM) for downstream analysis (Supplementary Data 10).
Bacterial alpha-diversity for genus-level transcriptional contribution to
functionalities (GO categories) was expressed using the Gini–Simpson index (1-Λ).
Differential expression of functional categories was determined by statistical
comparison of the calculated log2 fold change between bacterial communities using
a Kruskal–Wallis test with Benjamini–Hochberg FDR correction for multiple
comparisons. Functional categories were considered to be significantly
differentially expressed if adjusted p-value ≤ 0.05 and log2 fold change was ≥2. GO
network graphs were constructed using the Python3 Networkx module,
considering all nodes and connecting edges along the longest path to the biological
process root node (GO:0008150). For analysis of the bacterial metabolic profile,
redundant KEGG pathway annotations were removed by selecting parsimonious
KEGG pathway sets based on the KEGG link database (release 85.1) using MinPath
1.468.
Virulence factor gene level annotation. The majority of highly abundant genera
associated with polymicrobial infections were underrepresented or non-existing in
relevant virulence factor databases, hindering analysis of the virulence mechanisms
contributing to disease pathogenesis. To mitigate this problem, a strategy was
developed to analyze the virulence potential of the bacterial communities in NSTIs
based on conserved protein domains of gene products. A library of InterPro
domains associated with the terms ‘toxin’, ‘innate immune evasion’, ‘proteolysis’
and ‘adhesion’ was generated (Supplementary Data 6), where InterPro domains
were sorted into one of these categories, if; (I) a relevant GO term was associated
with the domain (GO terms ‘proteolysis’ (GO:0006508), ‘pathogenesis’
(GO:0009405), ‘adhesion’ (GO:0022610), ‘cell killing’ (GO:0001906), and their
respective child terms), (II) a gene product associated with a respective domain had
experimentally validated mechanistic relevance for one of the categories, (III) the
InterPro domain description showed semantic association to one of these disease
relevant processes (e.g. immune evasion). The InterPro domain architecture of all
expressed gene clusters was queried for InterPro domains that were classified into
one of the analyzed virulence-associated categories. The relevance of all identified
features for host-pathogen interaction was further inferred by in silico prediction of
their cellular export using SignalP 4.0, which identifies signal peptides for cellular
export using neural networks (D-cutoff values ‘sensitive’)69, and SecretomeP 2.0,
predicting non-signal peptide mediated protein secretion ab initio70. The validity of
the above-mentioned strategy for identifying potential virulence features in bac-
terial communities was demonstrated using well-known virulence and virulence-
associated gene clusters of S. pyogenes annotated by querying the Virulence Factor
Database VFDB (December 2017)70. Virulence factors from S. pyogenes, S. dys-
galactiae and S. agalactiae and their cognate locus tags were extracted from the
VFDB and used to identify respective gene clusters.
Quantitative RT-PCR. The expression of a set of genes indicated by RNA-Seq as
differentially expressed between monomicrobial and polymicrobial NSTIs was
further evaluated by qRT-PCR (Supplementary Figure 14), Total RNA samples
were reverse transcribed and amplified using the SensiFAST™ SYBR® No-ROX Kit
(Bioline) following the manufacturer’s instructions. Primer sequences are provided
in Supplementary Table 3. Thermal cycling conditions for all reactions were the
following: reverse transcription for 20 min at 45 °C, initial denaturation for 5 min
at 95 °C, 40 cycles of 20 s at 95 °C, 20 s at 60 °C and 20 s at 72 °C. Fold change
values were calculated using Pfaffl’s method for relative quantification in real-time
RT-PCR71.
Determination of cytokines and chemokines concentrations. Plasma con-
centrations of cytokines/chemokines were determined using the bead-based mul-
tiplex immunoassay LegendplexTM (Biolegend) according to the manufacturer’s
protocol. Available plasma samples taken from all patients included in the RNA-
seq analysis on day 0 were used in the multiplex imunnoassay.
Statistical analysis of plasma markers. The Student t test and One-way ANOVA
were used to evaluate the significance of differences in plasma marker con-
centrations between the different patient groups. Model performance was evaluated
based on a training cohort, not considering samples with missing values, through
10 × 2 repeated stratified K-fold crossvalidation to ensure representation of the
minority class in each sample split. Model parameters were optimized through a
grid search approach to maximize the correct classification of the positive class
(streptococcal NSTIs), represented by recall and precision score. Based on grid
search L2-regularized Logistic Regression classifier (C: 1.0) and SVM classifier
(kernel: linear, C: 10.0, gamma: 1.0) for standard scaled data, as well as Random
Forest classifier (number of trees: 250, max features at each split: sqrt(n_features),
minimal terminal leaf size: 3) for unscaled data were included in model compar-
isons. Feature selection was conducted using the Boruta algorithm which works as
a wrapper algorithm around random forests (RF), performs a test for statistical
significance of variable importances compared to a permutated copy of the original
dataset (shadow dataset) and outputs a distribution of Z-scores for each feature72.
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Only the features with Z-scores statistically higher than the maximum achieved
distribution for the shadow dataset were considered important. The final model
was trained on the whole training cohort considering only the most important
features (CXCL9, CXCL 10, CXCL11) and was evaluated using an independent test
cohort of NSTI patients (32 polymicrobial non-streptococcal and 27 S. pyogenes
NSTIs, see Supplementary Data 3) that had been kept separate during model
training. For evaluation of the classifier performance, receiver operation char-
acteristic (ROC) curves and the corresponding area under the curve (AUC) were
built by plotting the true positive rate (sensitivity) against the false positive rate (1-
specificity) for every likely cutoff between the 2 classes. Models were constructed,
assessed and validated using the Python package ‘sklearn’. Statistical analysis and
plotting were done using the Python package matplotlib and Graph Pad Prism
(Graph Pad Software, Inc.).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The sequencing data supporting the findings of this study have been deposited in the
NCBI BioProject database with accession number PRJNA479582. The source data
underlying all main text and supplementary figures are provided as a Source Data file. All
other relevant data are available as Supplementary Data or available from the
corresponding author.
Code availability
The analysis underlying Figs. 3, 4b and 7 have been implemented in Python and R, and
the source code can be downloaded from github [https://github.com/
MolProfileStrepNSTI/NSTI_src_code].
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